Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4787)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2017 (publication date) through Nov 30, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Adhoute X, Pénaranda G, Raoul JL, Bourlière M. Usefulness of the MESH score in a European hepatocellular carcinoma cohort. World J Hepatol 2017; 9(15): 711-714 [PMID: 28596819 DOI: 10.4254/wjh.v9.i15.711] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i15/711.htm |
| Number | Citing Articles |
| 1 |
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, Marc Bourlière. Intermediate stage treatment: Is TACE enough?. Liver International 2018; 38(1): 187 doi: 10.1111/liv.13598
|
| 2 |
Sophia Heinrich, Martin Sprinzl, Irene Schmidtmann, Elena Heil, Sandra Koch, Carolin Czauderna, Bernd Heinrich, Laurence Philippe P Diggs, Marcus‐Alexander Wörns, Roman Kloeckner, Peter R Galle, Jens U Marquardt, Arndt Weinmann. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. United European Gastroenterology Journal 2020; 8(4): 444 doi: 10.1177/2050640620904524
|
| 3 |
Giovanni Marasco, Franco Trevisani. Time to move beyond the classical prognostic systems for patients with advanced hepatocellular carcinoma undergoing Sorafenib. Digestive and Liver Disease 2021; 53(9): 1210 doi: 10.1016/j.dld.2021.04.037
|
| 4 |
Xavier Adhoute, Guillaume Penaranda, Jean‐Luc Raoul, Marc Bourlière. Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?. Liver International 2018; 38(1): 184 doi: 10.1111/liv.13516
|